Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaPeter G. Pappas, Jack D. Sobe, Carol A. Kauffman et al.|Clinical Infectious Diseases|2009Cited by 3.2k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusThomas J. Walsh, J. Peter Donnelly, J. E. Edwards et al.|Clinical Infectious Diseases|2002Cited by 2.3k
Guidelines for Treatment of CandidiasisPeter G. Pappas, John E. Edwards, John Rex et al.|Clinical Infectious Diseases|2004Cited by 1.4k
Practice Guidelines for the Treatment of CandidiasisJohn Rex, John E. Edwards, Thomas J. Walsh et al.|Clinical Infectious Diseases|2000Cited by 927
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsJohn Rex, A L Barry, Michael A. Pfaller et al.|Clinical Infectious Diseases|1997Cited by 863